Your browser is no longer supported. Please, upgrade your browser.
NVIV InVivo Therapeutics Holdings Corp. daily Stock Chart
NVIV [NASD]
InVivo Therapeutics Holdings Corp.
Index- P/E- EPS (ttm)-101.34 Insider Own0.18% Shs Outstand7.74M Perf Week-0.99%
Market Cap15.56M Forward P/E- EPS next Y-1.11 Insider Trans0.00% Shs Float7.74M Perf Month5.79%
Income-31.70M PEG- EPS next Q-0.38 Inst Own9.10% Short Float2.94% Perf Quarter-1.95%
Sales- P/S- EPS this Y-7.40% Inst Trans- Short Ratio1.98 Perf Half Y-78.62%
Book/sh-1.10 P/B- EPS next Y90.40% ROA-181.90% Target Price6.00 Perf Year-94.64%
Cash/sh- P/C- EPS next 5Y- ROE-412.50% 52W Range1.63 - 37.50 Perf YTD-89.56%
Dividend- P/FCF- EPS past 5Y-38.70% ROI- 52W High-94.56% Beta2.14
Dividend %- Quick Ratio0.90 Sales past 5Y- Gross Margin- 52W Low25.11% ATR0.10
Employees12 Current Ratio0.90 Sales Q/Q- Oper. Margin- RSI (14)57.32 Volatility5.37% 5.43%
OptionableNo Debt/Eq- EPS Q/Q-51.90% Profit Margin- Rel Volume0.48 Prev Close2.01
ShortableYes LT Debt/Eq- EarningsNov 06 AMC Payout- Avg Volume114.78K Price2.04
Recom1.00 SMA202.56% SMA503.85% SMA200-73.59% Volume39,967 Change1.49%
Jul-31-17Downgrade Raymond James Outperform → Mkt Perform
May-05-17Downgrade Raymond James Strong Buy → Outperform
Jul-21-16Initiated Ladenburg Thalmann Buy
Jul-07-16Initiated Raymond James Strong Buy $13
Oct-02-18 08:00AM  InVivo Therapeutics Announces Joint Research Collaboration with Q Therapeutics, Inc. Business Wire
Oct-01-18 08:00AM  InVivo Therapeutics Announces Publication of Neuro-Spinal Scaffold Preclinical Data in Peer-Reviewed Journal Biomaterials Business Wire
Sep-28-18 08:05AM  InVivo Therapeutics Announces Presentation at the Ladenburg Thalmann 2018 Healthcare Conference and Provides Business Update Business Wire
Aug-28-18 08:00AM  InVivo Therapeutics Announces Complete 12-Month Data from the INSPIRE Study of the Investigational Neuro-Spinal Scaffold in Acute Thoracic Complete Spinal Cord Injury Business Wire
Aug-07-18 07:42PM  InVivo: 2Q Earnings Snapshot Associated Press
04:30PM  InVivo Therapeutics Reports 2018 Second Quarter Financial Results Business Wire
Jun-25-18 04:05PM  InVivo Therapeutics Announces Closing of $15.2 Million Public Offering, Including the Exercise of Underwriters Overallotment Option Business Wire
Jun-21-18 09:00AM  InVivo Therapeutics Announces Pricing of $13.2 Million Underwritten Public Offering Business Wire -44.51%
May-24-18 10:35AM  Is InVivo Therapeutics Holdings Corps (NASDAQ:NVIV) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
May-07-18 06:44PM  InVivo: 1Q Earnings Snapshot Associated Press +6.55%
04:30PM  InVivo Therapeutics Reports 2018 First Quarter Financial Results Business Wire
Apr-18-18 08:20AM  Todays Research Reports on Stocks to Watch: vTv Therapeutics and InVivo Therapeutics ACCESSWIRE -9.26%
Apr-09-18 08:00AM  InVivo Therapeutics Provides Business Update Business Wire -30.27%
Mar-19-18 08:00AM  InVivo Therapeutics Announces Contemporary Thoracic SCI Registry Study (the CONTEMPO Registry Study) Findings Business Wire -7.47%
Mar-12-18 08:35AM  InVivo reports 4Q loss Associated Press -7.61%
08:15AM  InVivo Therapeutics Reports 2017 Year-end Financial Results Business Wire
Mar-09-18 10:34AM  Is It Time To Buy InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)? Simply Wall St. -7.72%
08:20AM  Todays Research Reports on Stocks to Watch: Johnson & Johnson and InVivo Therapeutics ACCESSWIRE
Mar-08-18 08:00AM  InVivo Therapeutics Receives FDA Approval for Pivotal, Randomized, Controlled Trial of the Neuro-Spinal Scaffold in Patients with Acute Spinal Cord Injury Business Wire +49.37%
Feb-05-18 08:00AM  InVivo Therapeutics Announces Appointment of Richard Toselli, M.D., as President and Chief Executive Officer Business Wire
Jan-29-18 07:00AM  Blog Exposure - InVivo Therapeutics Signs Share Repurchase Agreement with Lincoln Park Capital ACCESSWIRE -13.42%
Jan-26-18 08:00AM  InVivo Therapeutics Announces Purchase Agreement for up to $15 Million with Lincoln Park Capital Business Wire
Jan-03-18 08:00AM  InVivo Therapeutics Announces Latest Results from INSPIRE and Provides Update on Proposed Clinical Path Forward Business Wire -21.43%
Dec-18-17 08:00AM  InVivo Therapeutics Announces Executive Management and Board Changes Business Wire
Nov-06-17 08:00AM  InVivo Therapeutics to Present at Canaccord Genuitys Medical Technologies & Diagnostics Forum Business Wire
Oct-30-17 06:03PM  InVivo reports 3Q loss Associated Press
04:45PM  InVivo Therapeutics Provides Business Update and Reports 2017 Third Quarter Financial Results Business Wire
Oct-11-17 10:14AM  What Is InVivo Therapeutics Holdings Corps (NVIV) Share Price Doing? Simply Wall St.
Oct-10-17 08:00AM  InVivo Therapeutics Announces Oral Platform Presentation at 2017 Congress of Neurological Surgeons Annual Meeting Business Wire
Sep-20-17 08:00AM  InVivo Therapeutics to Present at Ladenburg Thalmann 2017 Healthcare Conference Business Wire
Sep-05-17 08:00AM  InVivo Therapeutics Announces Publication in Neurosurgery of Lifetime Hospitalization Costs for Thoracic Spinal Cord Injury Patients by Severity Grade Business Wire
Aug-29-17 05:59PM  InVivo slashes staff and ousts science chief American City Business Journals
Aug-28-17 04:30PM  InVivo Therapeutics Announces Strategic Corporate Restructuring Business Wire
Aug-10-17 09:00AM  InVivo Therapeutics Announces Exchange of Certain Warrants for Common Stock Business Wire -30.00%
Aug-09-17 11:37PM  InVivo reports 2Q loss Associated Press
Aug-08-17 06:00PM  InVivo Therapeutics Provides Business Update and Reports 2017 Second Quarter Financial Results Business Wire -10.00%
08:00AM  InVivo Therapeutics to Present at Canaccord Genuitys 37th Annual Growth Conference Business Wire
Aug-01-17 08:00AM  Today's Research Reports on Stocks to Watch: InVivo Therapeutics Holdings and Dynavax Technologies ACCESSWIRE -5.56%
Jul-31-17 12:46PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of InVivo Therapeutics Holding Corp. (NVIV) PR Newswire -26.53%
11:23AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of InVivo Therapeutics Holding Corp. - NVIV ACCESSWIRE
09:45AM  InVivo halts trial of spine injury treatment after third patient dies American City Business Journals
08:00AM  InVivo Therapeutics Announces Updates on the INSPIRE Study Business Wire
Jul-12-17 08:00AM  InVivo Therapeutics Announces Stanford Medicine as New Site for INSPIRE Study Business Wire
Jul-11-17 08:00AM  InVivo Therapeutics Opens First Site in the United Kingdom for INSPIRE Study Business Wire
Jul-10-17 08:00AM  InVivo Therapeutics Appoints Richard Toselli, M.D. as Chief Medical Officer Business Wire -5.32%
Jun-29-17 08:00AM  InVivo Therapeutics Announces UCHealth Memorial Hospital as New Site for INSPIRE Study Business Wire
Jun-28-17 09:45AM  Wednesdays Biggest Early Market Movers 24/7 Wall St.
08:00AM  InVivo Therapeutics Announces Positive Motor Recovery Assessments in Two Patients in the INSPIRE Study of the Neuro-Spinal Scaffold Business Wire
Jun-27-17 08:00AM  InVivo Therapeutics Announces New Patient Enrollment into The INSPIRE Study at Thomas Jefferson University Hospital Business Wire +7.84%
Jun-20-17 08:00AM  InVivo Therapeutics Announces New Patient Enrollment into The INSPIRE Study at Allegheny General Hospital Business Wire +8.33%
Jun-12-17 08:00AM  InVivo Therapeutics to Present at JMP Securities Annual Life Sciences Conference Business Wire
Jun-01-17 08:00AM  InVivo Therapeutics Announces Posting of Management Presentation Recording from Annual Shareholders Meeting Business Wire +10.26%
May-30-17 08:00AM  InVivo Therapeutics Announces Update to the Contemporary Thoracic SCI Registry Study (the CONTEMPO Registry Study) Business Wire +5.13%
May-09-17 08:00AM  InVivo Therapeutics Announces Presentation at Combined Canadian Spinal Cord and Ontario Spinal Cord Injury Research Network Meeting Business Wire
May-08-17 08:00AM  InVivo Therapeutics Announces New Patient Enrollment into The INSPIRE Study at Oregon Health and Science University Business Wire
May-05-17 05:03AM  InVivo reports 1Q loss Associated Press -14.71%
May-04-17 04:36PM  InVivo Therapeutics Provides Clinical Update and Reports 2017 First Quarter Financial Results Business Wire
Apr-20-17 08:00AM  InVivo Therapeutics Announces Oral Presentations at the 2017 American Spinal Injury Association Annual Scientific Meeting Business Wire
Apr-10-17 08:00AM  InVivo Therapeutics Announces New Site for INSPIRE Study Business Wire
Apr-05-17 08:00AM  InVivo Therapeutics Announces New Patient Enrollment into the INSPIRE Study at the Carolinas Medical Center Business Wire
08:00AM  InVivo Therapeutics Announces New Patient Enrollment into the INSPIRE Study at the Carolinas Medical Center
Mar-31-17 04:04PM  INVIVO THERAPEUTICS HOLDINGS CORP. Files SEC form 8-K, Change in Directors or Principal Officers
Mar-30-17 08:00AM  InVivo Therapeutics Announces First Canadian Site for Cervical Spinal Cord Injury Study Business Wire
Mar-29-17 08:00AM  InVivo Therapeutics Appoints Christopher McNulty as Chief Financial Officer Business Wire
Mar-28-17 08:00AM  InVivo Therapeutics Announces Seventh Patient Conversion in The INSPIRE Study of the Neuro-Spinal Scaffold Business Wire
Mar-27-17 08:00AM  InVivo Therapeutics to Present at Needham and Companys 16th Annual Healthcare Conference Business Wire
Mar-23-17 08:00AM  InVivo to Initiate Cervical Spinal Cord Injury Study Business Wire
Mar-21-17 08:00AM  InVivo Therapeutics Announces Submission to the FDA of Its Nonclinical Studies Module for the Neuro-Spinal Scaffold Business Wire -8.24%
Mar-20-17 08:00AM  InVivo Therapeutics Announces Enrollment of New Patient into the INSPIRE Study at New Jerseys Cooper Neurological Institute Business Wire +6.25%
Mar-16-17 01:04PM  INVIVO THERAPEUTICS HOLDINGS CORP. Financials
Mar-15-17 08:00AM  InVivo Therapeutics Receives Clinical Trial Application Approval from UK's Medicines Healthcare Products Regulatory Agency Business Wire
Mar-10-17 04:46PM  InVivo reports 4Q loss
04:30PM  InVivo Therapeutics Reports 2016 Year-end Financial Results and Business Update Business Wire
04:10PM  INVIVO THERAPEUTICS HOLDINGS CORP. Files SEC form 10-K, Annual Report
Mar-09-17 08:00AM  InVivo Therapeutics Announces Enrollment of New Patient into the INSPIRE Study at Keck Hospital, University of Southern California Business Wire
Mar-08-17 11:03AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating InVivo Therapeutics Holdings Corp. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Feb-28-17 08:00AM  InVivo Therapeutics to Present and Exhibit at Spine Summit 2017 Business Wire
Feb-27-17 08:00AM  InVivo Therapeutics to Present at Cowen and Company 37th Annual Health Care Conference Business Wire
Feb-07-17 08:00AM  InVivo Therapeutics to Present at 2017 BIO CEO & Investor Conference Business Wire
Jan-26-17 08:19AM  INVIVO THERAPEUTICS HOLDINGS CORP. Files SEC form 8-K, Regulation FD Disclosure
Jan-25-17 11:40AM  InVivo Gains on Neuro-Spinal Scaffold Results at Investopedia
Jan-24-17 01:18PM  Here's Why InVivo Therapeutics is Gaining Today +13.10%
08:00AM  InVivo Therapeutics Announces Sixth Patient Conversion in The INSPIRE Study of the Neuro-Spinal Scaffold Business Wire
Jan-23-17 04:10PM  SEC halts trading in PixarBio amid concerns over stock manipulation at bizjournals.com
Jan-19-17 08:00AM  InVivo Therapeutics Announces New Patient Enrollment into The INSPIRE Study Business Wire
Jan-18-17 08:00AM  InVivo Therapeutics Featured in Nationally Syndicated Radio Segment Business Wire
Jan-17-17 08:00AM  InVivo Therapeutics Announces University of New Mexico Hospital as New Site for INSPIRE Study Business Wire
Jan-10-17 08:00AM  InVivo Therapeutics Announces INSPIRES 29th Clinical Site: Rhode Island Hospital Business Wire +8.43%
Jan-09-17 08:12AM  INVIVO THERAPEUTICS HOLDINGS CORP. Files SEC form 8-K, Regulation FD Disclosure
08:00AM  InVivo Therapeutics Announces St. Michaels Hospital as New Canadian Site for INSPIRE Study Business Wire
Jan-05-17 11:39AM  PixarBio Offers to Acquire InVivo for $77 Million at Investopedia -5.62%
Jan-04-17 09:51AM  With Trumpian flair, former CEO of InVivo announces unsolicited takeover offer at bizjournals.com +7.23%
Jan-03-17 04:15PM  InVivo Therapeutics Responds to PixarBio Announcement Business Wire
Dec-20-16 08:00AM  InVivo Therapeutics Announces New Patient Enrollment into the INSPIRE Study Business Wire
Dec-12-16 05:49PM  Should You Avoid Destination XL Group Inc (DXLG)? at Insider Monkey -5.32%
08:00AM  InVivo Therapeutics to Present at 2016 Tissue Engineering & Regenerative Medicine International Society Americas Conference Business Wire
Dec-08-16 08:09AM  INVIVO THERAPEUTICS HOLDINGS CORP. Files SEC form 8-K, Change in Directors or Principal Officers
08:00AM  InVivo Therapeutics Appoints Melanie Morel-Ferris, C.P.A. as Interim CFO, Replacing Steven McAllister in Role Business Wire
Nov-29-16 12:05PM  Invivo Therapeutics Holdings Corp. :NVIV-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016
Nov-17-16 08:00AM  InVivo Therapeutics Announces New Patient Enrollment into The INSPIRE Study Business Wire -7.21%
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. It is developing Neuro-Spinal Scaffold implant, an investigational bioresorbable polymer scaffold for implantation at the site of injury within a spinal cord. InVivo Therapeutics Holdings Corp. has research collaboration with the Q Therapeutics, Inc. for the evaluation of the combination of PLGA-PLL based Neuro-Spinal Scaffold with adult neural progenitor cells, including those from induced pluripotent stem cells. The company was founded in 2005 and is headquartered in Cambridge, Massachusetts.